These findings suggest that the genetic suppression of GTK has a profound effect on the abolishment of tumorigenesis of pancreatic cancer and reveal GTK as a metabolic target for cancer therapy. The gene discussed is KYAT1; the disease is familial pancreatic carcinoma.